Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2025)
Historic Current Assets for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $266.4 million.
- Ascentage Pharma Group International's Current Assets changed N/A to $266.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $266.4 million, marking a year-over-year change of. This contributed to the annual value of $202.0 million for FY2024, which is 618.0% up from last year.
- According to the latest figures from Q2 2025, Ascentage Pharma Group International's Current Assets is $266.4 million.
- Over the past 5 years, Ascentage Pharma Group International's Current Assets peaked at $266.4 million during Q2 2025, and registered a low of $186.7 million during Q4 2023.
- In the last 3 years, Ascentage Pharma Group International's Current Assets had a median value of $205.2 million in 2024 and averaged $219.5 million.
- The largest annual percentage gain for Ascentage Pharma Group International's Current Assets in the last 5 years was 992.94% (2024), contrasted with its biggest fall of 992.94% (2024).
- Over the past 3 years, Ascentage Pharma Group International's Current Assets (Quarter) stood at $186.7 million in 2023, then increased by 9.93% to $205.2 million in 2024, then rose by 29.83% to $266.4 million in 2025.
- Its last three reported values are $266.4 million in Q2 2025, $205.2 million for Q4 2024, and $186.7 million during Q4 2023.